Redwood City, CA – According to filings with the U.S. Securities and Exchange Commission, Rezolute is raising $56,990,020.00 in new funding. Sources indicate as part of senior management Chief Financial Officer, Keith Vendola played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Rezolute

Rezolute is a clinical stage biopharmaceutical company specializing in the development of innovative drug therapies to improve the lives of patients with metabolic and orphan diseases.

To learn more about Rezolute, visit http://www.rezolutebio.com/

Contact:
Keith Vendola, Chief Financial Officer
650-206-4507
https://www.linkedin.com/in/keithvendola/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved